Search

Background: Huashi Baidu granule (HSBD), an approved herbal formula for treating COVID-19, demonstrates safety and efficacy. Despite its market approval, the detailed methodology and identification of its active components remain unexplored, leaving its bioactive constituents and action mechanisms unclear. Methods: This study investigated the potential mechanisms of HSBD’s active ingredient in treating COVID-19. Our approach integrated various techniques, including the UHPLC-QqQ-MS/MS method, analysis of the GEO database, network pharmacology, surface plasmon resonance, molecular docking and molecular dynamics simulations, to formulate a comprehensive research strategy. Results: The UHPLC-QqQ-MS/MS method employed for HSBD analysis proved stable, reliable, and reproducible. We identified 25 principal components in HSBD, with 7 compounds detected in plasma, namely Pogostone, P-Hydroxybenzoic acid, Paeoniflorin, Rhein, Emodin, Ephedrine hydrochloride, and Pseudoephedrine hydrochloride. Protein-Protein Interaction (PPI) network analysis identified MMP9 as a pivotal target. Surface plasmon resonance analysis revealed that Paeoniflorin and Rhein exert their antiviral effects by interacting with RBD and ACE2. In contrast, Emodin’s antiviral mechanism predominantly involves binding to MMP9. Molecular docking results indicated strong binding affinities of Rhein and Paeoniflorin to the hACE2 protein, and high binding affinities of Emodin to the MMP9 protein, all of which were corroborated by molecular dynamics simulations. Conclusion: We investigated the methodology and identified the active components of HSBD, focusing on those absorbed into the plasma, to elucidate the effective material basis of HSBD in the treatment of COVID-19, our research offered insightful exploration into its mechanisms of action against COVID-19.

Objectives: To comprehensively analyze the randomized controlled clinical trials of integrated traditional Chinese medicine (TCM) and western medicine in the treatment of metabolic syndrome (MetS), and to explore the clinical efficacy and safety of different TCM combined with western medicine for MetS. The purpose of this study is to provide specific suggestions for clinical guidance in the treatment of MetS. Methods: A comprehensive literature review was conducted across several databases, including China Knowledge Network, Wanfang Data, VIP Information, China Biomedical Literature Service System, Embase, PubMed, and Web of Science, up to October 2023. The scope of this review was confined to RCTs focusing on the treatment of metabolic syndrome through an integrated approach of TCM and Western medicine. The primary efficacy endpoints analyzed were clinical efficacy, fasting blood glucose (FBG), triglyceride (TG), and high-density lipoprotein (HDL). Data synthesis and analysis were performed using Stata 16 and RevMan 5.4 for both traditional and network meta-analyses. Results: The findings from both traditional and network meta-analyses reveal that the combination of JiangZhiHuoXue pills (JZHX) + Conventional Western Medicine (CWM) significantly reduces FBG levels. Similarly, the AnShenNingXin capsules (ASNX) + CWM combination markedly lowers TG levels, while the FuFangQiMa capsules (FFQM) + CWM combination shows enhanced efficacy in elevating HDL levels. Notably, the combination of KangNing capsules (KNJN) + CWM demonstrates a more pronounced clinical effect compared to CWM/placebo alone. Conclusions: The study concludes that the synergistic combination of TCM and Western medicine exhibits superior therapeutic benefits in treating MetS compared to CWM/Placebo treatments alone. The combinations of JZHX, AXNX, FFQM, and KNJN with CWM emerge as potentially effective treatments.

Obesity presents a significant global health challenge, increasing the susceptibility to chronic conditions such as diabetes, cardiovascular disease, and hypertension. Within the context of obesity, lipid metabolism, adipose tissue formation, and inflammation are intricately linked to endoplasmic reticulum stress (ERS). ERS modulates metabolism, insulin signaling, inflammation, as well as cell proliferation and death through the unfolded protein response (UPR) pathway. Serving as a crucial nexus, ERS bridges the functionality of adipose tissue and the inflammatory response. In this review, we comprehensively elucidate the mechanisms by which ERS impacts adipose tissue function and inflammation in obesity, aiming to offer insights into targeting ERS for ameliorating metabolic dysregulation in obesity-associated chronic diseases such as hyperlipidemia, hypertension, fatty liver, and type 2 diabetes.

Aims/hypothesisThrough a comprehensive analysis of the clinical randomized controlled trials of traditional Chinese medicine (TCM) combined with conventional western medicine (CWM) in treating type 2 diabetes(T2DM) in the past ten years, the clinical efficacy and safety of different TCMs combined with CWM were explored. This study aimed to provide specific suggestions for clinical guidance on treating T2DM.MethodsA literature search was conducted in CNKI, WanFang, VIP, CBM, PubMed, Embase, and Web of Science. The search time was limited from 2010 to the present time. The literature type was a controlled clinical trial study of TCM combined with CWM intervention in treating T2DM. The outcome indices of the efficacy evaluation included fasting blood glucose (FBG), 2-hour postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), adverse reactions, and clinical efficacy. Stata 15 and RevMan 5.4 software were used to conduct a network meta-analysis and a traditional meta-analysis.ResultsThe results showed that shenqi jiangtang granule combined with sulfonylurea, shenqi jiangtang granules combined with metformin and jinlida granules combined with insulin had significant effects on reductions in FBG, 2hPG and clinical efficacy compared with western medicines alone, which included fasting blood glucose [MD=-2.17, 95%CI=(-2.50, -1.85)], blood sugar at 2 hours after a meal [MD=-1.94, 95%CI=(-2.23, -1.65)], and clinical curative effect [OR= 1.73, 95%CI=(0.59, 2.87)].ConclusionsTCM combined with CWM has a very significant effect on treating T2DM compared with CWM alone. According to the network meta-analysis, the best intervention measures of different TCMs for different outcome indicators were obtained.Systematic review registrationidentifier 42022350372.

Objective: The purpose of this study was to analyze the efficacy and safety of Chinese patent medicine in the treatment of blood glucose, blood lipid and insulin resistance in prediabetic patients through a meta-analysis of clinical trials. Methods: Randomized controlled trials of Chinese patent medicine in the treatment of prediabetes were searched in the databases of CNKI, WanFang, VIP, CBM, PubMed, Web of Science and Embase using the computer with the search deadline on June 2, 2022. The two researchers independently screened the literatures based on the inclusion and exclusion criteria, and the fasting blood glucose, postprandial blood glucose, glycated hemoglobin, insulin resistance index, blood lipids, prediabetes reversal rate and diabetes conversion rate were used as outcome indicators. The quality of the study was evaluated according to the Cochrane scale, and data were analyzed by RevMan software. Results: Sixteen clinical trial studies were eventually fitted into, and a meta-analysis was conducted on the included studies, and the final results showed as follows: Compared with conventional lifestyle intervention, the remedy of Chinese patent medicine intervention in prediabetes patients had significant effects on the outcome indicators, such as fasting blood glucose [MD = -0.36, 95%CI = (-0.45,-0.26), P < 0.00001], 2 h postprandial blood glucose [MD = -0.71, 95%CI = (-0.99,-0.42), P < 0.00001], glycated hemoglobin [MD = -0.33, 95%CI = (-0.48,-0.19), P < 0.00001], BMI [MD = -0.82, 95%CI = (-1.20,-0.44), P < 0.0001], insulin resistance index [MD = -0.20, 95%CI = (-0.29,-0.11), P < 0.00001], diabetes conversion rate [MD = 0.49, 95%CI = (0.34,0.70), P＜0.0001], and the differences were indicated as a statistically significant. However, the outcome indexes of TC, TG, HDL-C and LDL-C in blood lipid exhibited no significant effect, and no significant difference. Conclusions: The results indicated that Chinese patent medicine intervention could ameliorate the outcome indicators of prediabetes with significant efficacy and good safety. Its therapeutic effect was mainly manifested in blood glucose, insulin, body weight, and diabetes conversion rate. Chinese patent medicine maybe a promising avenue for prediabetes.

The pancreatic duodenum homeobox-1 (PDX-1) is a transcription factor encoded by a Hox-like homeodomain gene that plays a crucial role in pancreatic development, β-cell differentiation, and the maintenance of mature β-cell functions. Research on the relationship between PDX-1 and diabetes has gained much attention because of the increasing prevalence of diabetes melitus (DM). Recent studies have shown that the overexpression of PDX-1 regulates pancreatic development and promotes β-cell differentiation and insulin secretion. It also plays a vital role in cell remodeling, gene editing, and drug development. Conversely, the absence of PDX-1 increases susceptibility to DM. Therefore, in this review, we summarized the role of PDX-1 in pancreatic development and the pathogenesis of DM. A better understanding of PDX-1 will deepen our knowledge of the pathophysiology of DM and provide a scientific basis for exploring PDX-1 as a potential target for treating diabetes.

Chatter that occurs between a cutting tool and a workpiece greatly reduces the surface quality and production efficiency. Therefore, it is of great importance to predict and avoid chatter so as to guarantee the stability of the manufacturing process. To realise the accurate prediction of the stability boundary of machine tools, operational modal analysis (OMA) is increasingly receiving attention due to its adequate consideration of variations in working conditions in the industrial environment. However, because of the influence of harmonic components in the response signals, the accuracy in identifying the modal parameters is seriously compromised. In this paper, an adaptive complex Morlet filter (ACMF) is presented to remove the harmonic components by adaptively adjusting the centre frequency and bandwidth according to the local character of the ambient environment in a specific frequency range and filtering out harmonic components that are not strict integer multiples of the fundamental frequency owing to non-rigid periodic motion of the machine tool spindle. In order to show the effectiveness of the proposed method, milling experiments are carried out and experimental modal analysis (EMA) is utilised to make comparisons with the proposed method. Moreover, comparisons between the ACMF and two other typical filtering methods are made. The results indicate that the proposed method performs well in modal parameter recognition for machine tools. [ABSTRACT FROM AUTHOR]

Oak regeneration failures have been causing a slow decline in the occurrence of oak forest ecosystems in eastern North America. Accordingly, our study sought to determine a means of creating more vigorous and competitive oak seedlings by the addition of manganese (Mn) fertilizers. Seeds of northern red oak (Quercus rubra L.), chestnut oak (Quercus prinus L.), and red maple (Acer rubrum L.), one of oak’s major competitors in North America oak forest ecosystems, were sown in 0.7 liter pots that contained a growing medium mixture of peat moss, perlite, and sand in a ratio of 2:1:2, and germinated in a greenhouse. Three different chemical compound Mn fertilizer treatments—manganese chloride (0.16 mg L−1 Mn, MnCl2·4H2O), nanoparticle manganese in the form of manganese hydroxide (0.01 mg/L Mn, nanoparticle Mn(OH)2), and manganese hydroxide (0.01 mg L−1 Mn, Mn(OH)2)—and a treatment of Hoagland solution were applied to the planted seed. These treatments were compared to a control consisting of water, and treatments were applied twice a week over a 12 week period. Germination rates and seedling growth were measured over this period of time. At the end of 12 weeks seedlings were harvested, separated into roots, stem, and foliage for the purpose of biomass and nutrient analysis by seedling component. Northern red oak displayed a 100% germination success rate with MnCl2·4H2O and Mn(OH)2 treatments, while red maple germination was reduced with the MnCl2·4H2O and nanoparticle Mn(OH)2 treatments with only a 32% and 24% germination rate, respectively. The MnCl2·4H2O treatment produced the largest overall seedling size (basal diameter squared times the seedling height) of red maple with a 191.6% increase; however, the MnCl2·4H2O treatment produced the largest overall seedling size (basal diameter squared times the seedling height) of northern red oak and chestnut oak with an increase of 503.7% and 339.5%, respectively. The greatest increase in overall seedling size for northern red oak was with the Mn(OH)2 treatment at 507.2%, and 601.2% for chestnut oak with the nanoparticle Mn(OH)2 treatment. MnCl2·4H2O treatment significantly increased the oak foliar nitrogen (N) content. It appears that the application of Mn fertilizer can increase the germination and growth of these oak species while suppressing or having a lesser effect on red maple, thus creating a competitive advantage for oak over its competitor.